Influence of Roux-en-Y gastric bypass on plasma bile acid profiles: A comparative study between rats, pigs and humans

International Journal of Obesity

Volumn 40, Issue 8, 2016, Pages 1260-1267

  Spinelli, V ^a,b,c,d   Lalloyer, F ^a,b,c,d   Baud, G ^a   Osto, E ^e,f   Kouach, M ^a   Daoudi, M ^a   Vallez, E ^a,b,c,d   Raverdy, V ^a,c   Goossens, J F ^a   Descat, A ^a   Doytcheva, P ^f   Hubert, T ^a   Lutz, T A ^f   Lestavel, S ^a,b,c,d   Staels, B ^a,b,c,d   Pattou, F ^a,c   Tailleux, A ^a,b,c,d  

^a UNIV LILLE   (France)

^b INSERM   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d INSTITUT PASTEUR DE LILLE   (France)

^e ETH ZURICH   (Switzerland)

^f UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CHENODEOXYCHOLIC ACID; CHOLIC ACID; DEOXYCHOLIC ACID; GLYCOCONJUGATE;

ADULT; ANIMAL EXPERIMENT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; LIQUID CHROMATOGRAPHY; MALE; MINIPIG; NONHUMAN; OBESITY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; ROUX Y ANASTOMOSIS; STOMACH BYPASS; TANDEM MASS SPECTROMETRY; ANIMAL; BLOOD; BODY WEIGHT LOSS; COMPARATIVE STUDY; DISEASE MODEL; GASTRIC BYPASS SURGERY; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PIG; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

ADULT; ANIMALS; BILE ACIDS AND SALTS; BLOOD GLUCOSE; DISEASE MODELS, ANIMAL; FEMALE; GASTRIC BYPASS; HUMANS; MALE; MIDDLE AGED; OBESITY; RATS; SIGNAL TRANSDUCTION; SWINE; SWINE, MINIATURE; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84964318627     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2016.46     Document Type: Article

References (65)

1. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014; 384: 766-781
2. Cummings DE, Overduin J, Foster-Schubert KE. Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. J Clin Endocrinol Metab 2004; 89: 2608-2615
3. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-Analysis. Am J Med 2009; 122: 248-256
4. Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM, et al. Who would have thought it' An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995; 222: 339-350
5. Mummadi RR, Kasturi KS, Chennareddygari S, Sood GK. Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-Analysis. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 2008; 6: 1396-1402
6. Caiazzo R, Lassailly G, Leteurtre E, Baud G, Verkindt H, Raverdy V, et al. Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: a 5-year controlled longitudinal study. Ann Surg 2014; 260: 893-898
7. Ricci C, Gaeta M, Rausa E, Macchitella Y, Bonavina L. Early impact of bariatric surgery on type II diabetes, hypertension, and hyperlipidemia: a systematic review, metaanalysis and meta-regression on 6, 587 patients. Obes Surg 2014; 24: 522-528
8. Tailleux A, Rouskas K, Pattou F, Staels B. Bariatric surgery, lipoprotein metabolism and cardiovascular risk. Curr Opin Lipidol 2015; 26: 317-324
9. Lindqvist A, Spégel P, Ekelund M, Mulder H, Groop L, Hedenbro J, et al. Effects of ingestion routes on hormonal and metabolic profiles in gastric-bypassed humans. J Clin Endocrinol Metab 2013; 98: E856-E861
10. Wu Q, Xiao Z, Cheng Z, Tian H. Changes of blood glucose and gastrointestinal hormones 4 months after Roux-en-Y gastric bypass surgery in Chinese obese type 2 diabetes patients with lower body mass index. J Diabetes Invest 2013; 4: 214-221
11. Sweeney TE, Morton JM. The human gut microbiome: a review of the effect of obesity and surgically induced weight loss. JAMA Surg 2013; 148: 563-569
12. Ryan KK, Tremaroli V, Clemmensen C, Kovatcheva-Datchary P, Myronovych A, Karns R, et al. FXR is a molecular target for the effects of vertical sleeve gastrectomy. Nature 2014; 509: 183-188
13. Penney NC, Kinross JM, Newton RC, Purkayastha S. The role of bile acids in reducing the metabolic complications of obesity after bariatric surgery: a systematic review. Int J Obes 2015; 191: 127-139
14. Russell DW. The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem 2003; 72: 137-174
15. Lefebvre P, Cariou B, Lien F, Kuipers F, Staels B. Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev 2009; 89: 147-191
16. Claus SP, Ellero SL, Berger B, Krause L, Bruttin A, Molina J, et al. Colonizationinduced host-gut microbial metabolic interaction. mBio 2011; 2: e00271-00210
17. de Aguiar Vallim TQ, Tarling EJ, Edwards PA. Pleiotropic roles of bile acids in metabolism. Cell Metab 2013; 17: 657-669
18. Osto E, Doytcheva P, Corteville C, Bueter M, Dörig C, Stivala S, et al. Rapid and body weight-independent improvement of endothelial and high-density lipoprotein function after Roux-en-Y gastric bypass: role of glucagon-like peptide-1. Circulation 2015; 131: 871-881
19. Bruinsma BG, Uygun K, Yarmush ML, Saeidi N. Surgical models of Roux-en-Y gastric bypass surgery and sleeve gastrectomy in rats and mice. Nat Protoc 2015; 10: 495-507
20. Arble DM, Sandoval DA, Seeley RJ. Mechanisms underlying weight loss and metabolic improvements in rodent models of bariatric surgery. Diabetologia 2015; 58: 211-220
21. Seyfried F, le Roux CW, Bueter M. Lessons learned from gastric bypass operations in rats. Obes Facts 2011; 4(Suppl 1): 3-12
22. Shin AC, Zheng H, Townsend RL, Sigalet DL, Berthoud H-R. Meal-induced hormone responses in a rat model of Roux-en-Y gastric bypass surgery. Endocrinology 2010; 151: 1588-1597
23. Bhutta HY, Rajpal N, White W, Freudenberg JM, Liu Y, Way J, et al. Effect of Roux-en-Y gastric bypass surgery on bile acid metabolism in normal and obese diabetic rats. PLoS One 2015; 10: e0122273-e0122290
24. Potvin M, Gagner M, Pomp A. Laparoscopic Roux-en-Y gastric bypass for morbid obesity: a feasibility study in pigs. Surg Laparosc Endosc 1997; 7: 294-297
25. Cagigas JC, Martino E, Escalante CF, Ingelmo A, Estefanía R, Gutierrez JM, et al. Technical alternatives in laparoscopic distal gastric bypass for morbid obesity in a porcine model. Obes Surg 1999; 9: 166-170
26. Scott DJ, Provost DA, Tesfay ST, Jones DB. Laparoscopic Roux-en-Y gastric bypass using the porcine model. Obes Surg 2001; 11: 46-53
27. Gentileschi P, Gagner M, Milone L, Kini S, Fukuyama S. Histologic studies of the bypassed stomach after Roux-en-Y gastric bypass in a porcine model. Obes Surg 2006; 16: 886-890
28. Flum DR, Devlin A, Wright AS, Figueredo E, Alyea E, Hanley PW, et al. Development of a porcine Roux-en-Y gastric bypass survival model for the study of post-surgical physiology. Obes Surg 2007; 17: 1332-1339
29. Sham JG, Simianu VV, Wright AS, Stewart SD, Alloosh M, Sturek M, et al. Evaluating the mechanisms of improved glucose homeostasis after bariatric surgery in Ossabaw miniature swine. J Diabetes Res 2014; 2014: 526972-526979
30. Lindqvist A, Sp'gel P, Ekelund M, Garcia Vaz E, Pierzynowski S, Gomez MF, et al. Gastric bypass improves β-cell function and increases β-cell mass in a porcine model. Diabetes 2014; 63: 1665-1671
31. Verhaeghe R, Zerrweck C, Hubert T, Tréchot B, Gmyr V, D'Herbomez M, et al. Gastric bypass increases postprandial insulin and GLP-1 in nonobese minipigs. Eur Surg Res 2014; 52: 41-49
32. Laville M, Romon M, Chavrier G, Guy-Grand B, Krempf M, Chevallier JM, et al. Recommendations regarding obesity surgery. Obes Surg 2005; 15: 1476-1480
33. García-Cañaveras JC, Donato MT, Castell JV, Lahoz A. Targeted profiling of circulating and hepatic bile acids in human, mouse, and rat using a UPLC-MRM-MSvalidated method. J Lipid Res 2012; 53: 2231-2241
34. Ahlberg J, Angelin B, Björkhem I, Einarsson K. Individual bile acids in portal venous and systemic blood serum of fasting man. Gastroenterology 1977; 73: 1377-1382
35. McRae M, Rezk NL, Bridges AS, Corbett AH, Tien H-C, Brouwer KLR, et al. Plasma bile acid concentrations in patients with human immunodeficiency virus infection receiving protease inhibitor therapy: possible implications for hepatotoxicity. Pharmacotherapy 2010; 30: 17-24
36. Kasbo J, Saleem M, Perwaiz S, Mignault D, Lamireau T, Tuchweber B, et al. Biliary, fecal and plasma deoxycholic acid in rabbit, hamster, guinea pig, and rat: comparative study and implication in colon cancer. Biol Pharm Bull 2002; 25: 1381-1384
37. Patti M-E, Houten SM, Bianco AC, Bernier R, Larsen PR, Holst JJ, et al. Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism. Obesity (Silver Spring, MD) 2009; 17: 1671-1677
38. Nakatani H, Kasama K, Oshiro T, Watanabe M, Hirose H, Itoh H. Serum bile acid along with plasma incretins and serum high-molecular weight adiponectin levels are increased after bariatric surgery. Metabolism 2009; 58: 1400-1407
39. Pournaras DJ, Glicksman C, Vincent RP, Kuganolipava S, Alaghband-Zadeh J, Mahon D, et al. The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control. Endocrinology 2012; 153: 3613-3619
40. Simonen M, Dali-Youcef N, Kaminska D, Venesmaa S, Käkelä P, Pääkkönen M, et al. Conjugated bile acids associate with altered rates of glucose and lipid oxidation after Roux-en-Y gastric bypass. Obes Surg 2012; 22: 1473-1480
41. De Giorgi S, Campos V, Egli L, Toepel U, Carrel G, Cariou B, et al. Long-Term effects of Roux-en-Y gastric bypass on postprandial plasma lipid and bile acids kinetics in female non diabetic subjects: a cross-sectional pilot study. Clin Nutr 2014; 34: 911-917
42. Scholtz S, Miras AD, Chhina N, Prechtl CG, Sleeth ML, Daud NM, et al. Obese patients after gastric bypass surgery have lower brain-hedonic responses to food than after gastric banding. Gut 2014; 63: 891-902
43. Werling M, Vincent RP, Cross GF, Marschall H-U, Fändriks L, Lönroth H, et al. Enhanced fasting and post-prandial plasma bile acid responses after Roux-en-Y gastric bypass surgery. Scand J Gastroenterol 2013; 48: 1257-1264
44. Jansen PLM, Van Werven J, Aarts E, Berends F, Janssen I, Stoker J, et al. Alterations of hormonally active fibroblast growth factors after Roux-en-Y gastric bypass surgery. Dig Dis (Basel, Switzerland) 2011; 29: 48-51
45. Steinert RE, Peterli R, Keller S, Meyer-Gerspach AC, Drewe J, Peters T, et al. Bile acids and gut peptide secretion after bariatric surgery: a 1-year prospective randomized pilot trial. Obesity (Silver Spring, MD) 2013; 21: E660-E668
46. Jørgensen NB, Dirksen C, Bojsen-Møller KN, Kristiansen VB, Wulff BS, Rainteau D, et al. Improvements in glucose metabolism early after gastric bypass surgery are not explained by increases in total bile acids and fibroblast growth factor 19 concentrations. J Clin Endocrinol Metab 2015; 100: E396-E406
47. Dutia R, Embrey M, O'Brien S, Haeusler RA, Ag'nor KK, Homel P, et al. Temporal changes in bile acid levels and 12'-hydroxylation after Roux-en-Y gastric bypass surgery in type 2 diabetes. Int J Obes 2015; 39: 806-813
48. Albaugh VL, Flynn CR, Cai S, Xiao Y, Tamboli RA, Abumrad NN. Early increases in bile acids post Roux-en-Y gastric bypass are driven by insulin-sensitizing, secondary bile acids. J Clin Endocrinol Metab 2015; 100: E1225-E1233
49. Gerhard GS, Styer AM, Wood GC, Roesch SL, Petrick AT, Gabrielsen J, et al. A role for fibroblast growth factor 19 and bile acids in diabetes remission after Roux-en-Y gastric bypass. Diabetes Care 2013; 36: 1859-1864
50. Zhou D, Jiang X, Ding W, Zhang D, Yang L, Zhen C, et al. Impact of bariatric surgery on ghrelin and obestatin levels in obesity or type 2 diabetes mellitus rat model. J Diabetes Res 2014; 2014: 569435
51. Kohli R, Bradley D, Setchell KD, Eagon JC, Abumrad N, Klein S. Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids. J Clin Endocrinol Metab 2013; 98: E708-E712
52. Kohli R, Kirby M, Setchell KDR, Jha P, Klustaitis K, Woollett LA, et al. Intestinal adaptation after ileal interposition surgery increases bile acid recycling and protects against obesity-related comorbidities. Am J Physiol Gastrointest Liver Physiol 2010; 299: G652-G660
53. Goncalves D, Barataud A, De Vadder F, Vinera J, Zitoun C, Duchampt A, et al. Bile routing modification reproduces key features of gastric bypass in rat. Ann Surg 2015; 262: 1006-1015
54. Lutz TA, Bueter M. Physiological mechanisms behind Roux-en-Y gastric bypass surgery. Dig Surg 2014; 31: 13-24
55. Birck MM, Vegge A, Støckel M, Gögenur I, Thymann T, Hammelev KP, et al. Laparoscopic Roux-en-Y gastric bypass in super obese Göttingen minipigs. Am J Transl Res 2013; 5: 643-653
56. Parks DJ, Blanchard SG, Bledsoe RK, Chandra G, Consler TG, Kliewer SA, et al. Bile acids: natural ligands for an orphan nuclear receptor. Science 1999; 284: 1365-1368
57. Kawamata Y, Fujii R, Hosoya M, Harada M, Yoshida H, Miwa M, et al. A G proteincoupled receptor responsive to bile acids. J Biol Chem 2003; 278: 9435-9440
58. Sayin SI, Wahlström A, Felin J, Jäntti S, Marschall H-U, Bamberg K, et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-betamuricholic acid, a naturally occurring FXR antagonist. Cell Metab 2013; 17: 225-235
59. Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, et al. Identification of a nuclear receptor for bile acids. Science 1999; 284: 1362-1365
60. Cui J, Heard TS, Yu J, Lo J-L, Huang L, Li Y, et al. The amino acid residues asparagine 354 and isoleucine 372 of human farnesoid X receptor confer the receptor with high sensitivity to chenodeoxycholate. J Biol Chem 2002; 277: 25963-25969
61. Midtvedt T. Microbial bile acid transformation. Am J Clin Nutr 1974; 27: 1341-1347
62. Ridlon JM, Kang D-J, Hylemon PB. Bile salt biotransformations by human intestinal bacteria. J Lipid Res 2006; 47: 241-259
63. Swann JR, Want EJ, Geier FM, Spagou K, Wilson ID, Sidaway JE, et al. Systemic gut microbial modulation of bile acid metabolism in host tissue compartments. Proc Natl Acad Sci USA 2011; 108(Suppl 1): 4523-4530
64. Mueller M, Thorell A, Claudel T, Jha P, Koefeler H, Lackner C, et al. Ursodeoxycholic acid exerts farnesoid X receptor-Antagonistic effects on bile acid and lipid metabolism in morbid obesity. J Hepatol 2015; 62: 1398-1404
65. Song P, Rockwell CE, Cui JY, Klaassen CD. Individual bile acids have differential effects on bile acid signaling in mice. Toxicol Appl Pharmacol 2015; 283: 57-64